Reactions Weekly

, Volume 1658, Issue 1, pp 213–213 | Cite as

Gimeracil/oteracil/tegafur/protein tyrosine kinase inhibitors

Elevated total serum bilirubin: case report
Case report


  1. Yang L, et al. The combination therapy of S-1 and the epidermal growth factor receptor tyrosine kinase inhibitors beyond progressive disease. Journal of Thoracic Oncology 12 (Suppl. 1): S1242-S1243 abstr. P3.02b-085, Jan 2017. Available from: URL: [abstract] -China

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations